Demars Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Demars Financial Group's BMY Position: Q2 2026 in Review
Demars Financial Group increased its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, buying an estimated $318K and bringing the position to 30,977 shares worth $1.78M. The position accounts for 0.49% of the portfolio, ranked #26.
Demars Financial Group first reported a position in BMY in Q2 2021 and has held it in 19 quarters since. The position peaked at $15.8M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Demars Financial Group held 30,977 shares of Bristol-Myers Squibb worth $1.78M as of Q2 2026.
- Demars Financial Group bought 5,541 Bristol-Myers Squibb shares in Q2 2026, an estimated $318K.
- Bristol-Myers Squibb made up 0.49% of Demars Financial Group's portfolio in Q2 2026, its #26 holding.
- Demars Financial Group first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 19 quarters since.
- Demars Financial Group's Bristol-Myers Squibb position peaked at $15.8M in Q1 2025.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Demars Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.